KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Acquisitions (2016 - 2025)

Humana (HUM) has disclosed Acquisitions for 14 consecutive years, with $76.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Acquisitions changed N/A to $76.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $81.0 million, a N/A change, with the full-year FY2025 number at $81.0 million, down 8.99% from a year prior.
  • Acquisitions was $76.0 million for Q4 2025 at Humana, up from $4.0 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $3.6 billion in Q3 2021 to a low of $1.0 million in Q2 2025.
  • A 4-year average of $440.6 million and a median of $84.5 million in 2022 define the central range for Acquisitions.
  • Peak YoY movement for Acquisitions: plummeted 96.53% in 2022, then dropped 1.35% in 2023.
  • Humana's Acquisitions stood at $3.6 billion in 2021, then tumbled by 96.53% to $126.0 million in 2022, then crashed by 42.06% to $73.0 million in 2023, then rose by 4.11% to $76.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Acquisitions are $76.0 million (Q4 2025), $4.0 million (Q3 2025), and $1.0 million (Q2 2025).